Fish & Richardson Named to NLJ 2015 Appellate Hot List; Marks Fifth Year on Prestigious List

BOSTON, MA--(Marketwired - Nov 18, 2015) - Fish & Richardson has been named to the National Law Journal's (NLJ) "2015 Appellate Hot List" as one of 20 firms that "represent appellate advocacy at its strongest -- winning the big cases and changing the law." This is the fifth time that Fish has been named to the Appellate Hot List.

The NLJ noted in its profile that, "Fish & Richardson likes a dual perspective on appeal. It commonly uses the firm lawyer who ran the trial to present oral arguments -- with the help of a fresh take from at least one attorney in the firm's appellate practice."

The NLJ highlighted Fish's two wins at the U.S. Court of Appeals for the Federal Circuit for long-time client Allergan PLC as an example of this winning strategy. In August 2015, the Federal Circuit affirmed a win that blocks Allergan's four competitors from selling a generic version of the LUMIGAN 0.01% glaucoma treatment, which has $200 million in annual sales, until 2027. In December 2014, the Federal Circuit's ruling maintained patent protection for Allergan's glaucoma drug Combigan, which has over $200 million in annual sales, until 2022. This ruling "affirmed the importance of fairness in the litigation of these drug cases," said Jonathan Singer, the principal who was lead counsel on the appeal.

The NLJ also cited Fish's work for client LG Chem Ltd. in an important patent case over lithium battery technology. In August 2015 the Federal Circuit issued a full reversal of a preliminary injunction against LG Chem by showing that Celgard did not meet the irreparable harm standard and that the balance of equities and the public interest did not support an injunction. According to Michael McKeon, a Fish principal who was co-lead counsel, "maintaining access to LG Chem products is critical" for many consumer electronics and electric vehicle industries.

Fish & Richardson is a global patent, intellectual property (IP) litigation, and commercial litigation law firm with more than 400 attorneys and technology specialists across the U.S. and Europe. Fish has been named the #1 patent litigation firm in the U.S. for 12 consecutive years. Fish has been winning cases worth billions in controversy -- often by making new law -- for the most innovative clients and influential industry leaders since 1878. For more information, visit www.fr.com.